Cooperative Agreement To Support Shellfish Safety Assistance Project, 37815-37817 [2011-16119]
Download as PDF
37815
Federal Register / Vol. 76, No. 124 / Tuesday, June 28, 2011 / Notices
information regarding the use of edible
tissues from investigational animals.
Part 511 also requires that records be
established and maintained to
document the distribution and use of
the investigational drug to assure that its
use is safe, and that the distribution is
controlled to prevent potential abuse.
The Agency uses these required records
under its Bio-Research Monitoring
Program to monitor the validity of the
studies submitted to FDA to support
new animal drug approval and to assure
that proper use of the drug is
maintained by the investigator.
Investigational new animal drugs are
used primarily by drug industry firms,
academic institutions, and the
government. Investigators may include
individuals from these entities as well
as research firms and members of the
medical professional. Respondents to
this collection of information are the
persons who use new animal drugs
investigationally.
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
21 CFR Part
511.1(b)(4)
511.1(b)(5)
511.1(b)(6)
511.1(b)(8)
511.1(b)(9)
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
Total hours
...........................................................................
...........................................................................
...........................................................................
(ii) ......................................................................
...........................................................................
206
206
206
206
206
6.01
.34
.01
.07
.07
1,238
70
2
15
15
1
8
1
2
8
1,238
560
2
30
120
Total ..............................................................................
........................
........................
........................
........................
1,950
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN
Number of
recordkeepers
21 CFR Part
Number of
records per
recordkeeper
Total annual
records
Average
burden per
recordkeeping
Total hours
511.1(a)(3) ...........................................................................
511.1(b)(3) ...........................................................................
511.1(b)(7)(ii) .......................................................................
511.1(b)(8)(i) ........................................................................
206
206
206
206
2.30
6.01
6.01
6.01
473
1238
1238
1238
1
1
3.5
3.5
473
1,238
4,333
4,333
Total ..............................................................................
........................
........................
........................
........................
10,377
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
mstockstill on DSK4VPTVN1PROD with NOTICES
The estimate of the time required for
reporting requirements, record
preparation, and maintenance for this
collection of information is based on
Agency communication with industry.
Based on the number of sponsors
subject to animal drug user fees, FDA
estimates that there are 206
respondents. We use this estimate
consistently throughout the table and
calculate the ‘‘No. of Responses per
Respondent’’ by dividing the total
annual responses by number of
respondents. Additional information
needed to make a final calculation of the
total burden hours (i.e., the number of
respondents, the number of
recordkeepers, the number of NCIEs
received, etc.) is derived from Agency
records.
Dated: June 22, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–16090 Filed 6–27–11; 8:45 am]
BILLING CODE 4160–01–P
VerDate Mar<15>2010
16:46 Jun 27, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
3. The opening date is June 28, 2011.
4. The expiration date is July 16,
2011.
Food and Drug Administration
FOR FURTHER INFORMATION AND
ADDITIONAL REQUIREMENTS CONTACT:
[Docket No. FDA–2011–N–0010]
Cooperative Agreement To Support
Shellfish Safety Assistance Project
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA), Center for Food
Safety and Applied Nutrition (CFSAN),
Office of Food Safety is announcing its
intent to award a single source
cooperative agreement to support the
Interstate Shellfish Sanitation
Conference (ISSC). The purpose of this
cooperative agreement is to enhance the
FDA molluscan shellfish sanitation
program and provide the public greater
assurance of the quality and safety of
these products.
DATES: Important dates are as follows:
1. The application due date is July 15,
2011.
2. The anticipated start date is
September 1, 2011.
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
For Programmatic and Technical
Concerns and Questions: Paul
DiStefano, Center for Food Safety and
Applied Nutrition (HFS–325), Food and
Drug Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 240–
402–1410.
For Administrative and Financial
Concerns and Questions: Gladys
Melendez-Bohler, Office of Acquisitions
and Grants Services (HFA–500), Food
and Drug Administration, 5630 Fishers
Lane, rm. 1078, Rockville, MD 20857,
301–827–7175.
SUPPLEMENTARY INFORMATION:
I. Funding Opportunity Description
RFA–FD–11–023, 93.103.
A. Background
The CFSAN Office of Food Safety is
announcing its intent to award, a single
source cooperative agreement to the
ISSC in the amount of $325,000 for
fiscal year 2011, direct and indirect
costs combined. Subject to the
E:\FR\FM\28JNN1.SGM
28JNN1
37816
Federal Register / Vol. 76, No. 124 / Tuesday, June 28, 2011 / Notices
availability of Federal funds and
successful performance, 4 additional
years of support will be available. This
effort will enhance FDA’s molluscan
shellfish sanitation program and
provide the public greater assurance of
the quality and safety of these products.
Molluscan shellfish have been
recognized by FDA as a significant
source of seafood-borne illnesses and
continue to be the subject of
congressional, State, industry, and
public concern. FDA has given high
priority to enhance the Agency’s
shellfish safety program and to provide
the public greater assurance of the
quality and safety of these products.
FDA administers the National Shellfish
Sanitation Program (NSSP). Under that
program the NSSP Model Ordinance
serves as guidance for State shellfish
sanitation programs and the issuance of
State regulations and laws concerning
shellfish safety. This cooperative
agreement will enhance FDA efforts to
help ensure that shellfish is free of
harmful pathogens.
mstockstill on DSK4VPTVN1PROD with NOTICES
B. Research Objectives
This proposed cooperative agreement
with ISSC will continue to: (1) Address
the need to improve information
exchange and transfer among States,
Federal Agencies, industry, and
consumers; (2) strengthen State
activities by providing them with
procedural and policy guidance,
technical training, research, consumer
education, and support for States to
participate in ISSC biennial meetings
and ISSC committee meetings; and (3)
promote efforts and projects, including
research, that will contribute
significantly to the ability of FDA and
States to identify and implement
scientifically defensible food safety
controls to reduce the risk of illness
associated with molluscan shellfish
consumption, including Vibrio
vulnificus and V. parahaemolyticus.
Research efforts will provide
information and data that can be used
to reduce assumptions and tighten
modeling outputs of the V. vulnificus
and V. parahaemolyticus risk
assessments developed by the Food and
Agriculture Organization of the World
Health Organization and FDA.
Substantive accomplishments of the
ISSC under previous cooperative
agreements include:
1. Coordination of annual shellfish
safety meetings of Federal regulators,
State regulators, and industry members
for the purpose of developing improved
science based shellfish safety controls in
the NSSP Model Ordinance for
implementation by State shellfish
VerDate Mar<15>2010
16:46 Jun 27, 2011
Jkt 223001
control agencies and the shellfish
industry;
2. Facilitation of the incorporation
and implementation of Hazard Analysis
and Critical Control Point (HACCP) into
the NSSP Model Ordinance;
3. Facilitation of an ISSC Unresolved
Issues Process to resolve shellfish safety
program discrepancies between FDA
and States, ensuring continued
compliance with NSSP shellfish safety
controls;
4. Coordination of NSSP Model
Ordinance revisions and electronic
online availability;
5. Coordination with FDA on the
development and oversight of a V.
parahaemolyticus control plan;
6. Development of an educational
training video concerning the risks and
control of illegal shellfish harvesting;
7. Development of an education
training video concerning the public
health implications associated with
overboard waste discharges from harvest
vessels;
8. Development of accredited online
training courses for medical
professionals concerning Vibrio illness
and shellfish consumption;
9. Development and maintenance of a
World Wide Web site for continuous
accessibility to molluscan shellfish
safety information, including up-to-date
information regarding outbreaks and
recalls;
10. Coordination, development and
oversight of a V. vulnificus control plan;
11. In conjunction with FDA, conduct
of retail and processing plant product
sampling studies to examine Vibrios in
molluscan shellfish that have undergone
a post harvest process to reduce levels
of Vibrios; and;
12. In conjunction with FDA, conduct
of a retail shellfish study to look at the
occurrence of pathogens in molluscan
shellfish, including norovirus, Hepatitis
A virus, Salmonella, and Vibrios; and
13. In conjunction with FDA,
development of a risk-based approach to
evaluating State compliance with NSSP
Model Ordinance requirements for
controlling the safety of molluscan
shellfish.
Other substantive accomplishments of
the ISSC include facilitating and
coordinating development of shellstock
time-temperature controls for V.
vulnificus and V. parahaemolyticus;
funding support for V. vulnificus
virulent strain identification research;
funding support to research the effects
of ice chilling on V. vulnificus; funding
support to research the influence of
water and air temperature, dissolved
oxygen, and nutrients on V.
parahaemolyticus concentrations in
Pacific oysters; funding support to
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
conduct an economic assessment of
mandating post-harvest treatment of
oysters; funding support to conduct a
consumer acceptance study of oysters
that have been post-harvest treated to
reduce Vibrio levels to nondetect;
development of a V. vulnificus
laboratory methodology training video;
and development and broadcast of a
public service announcement to alert at
risk consumers of the dangers associated
raw shellfish consumption.
This project will (1) enhance both the
effectiveness and uniformity of the
national molluscan shellfish safety
program by improving the flow of
information between Federal and State
regulatory agencies, industry, and
consumers; (2) strengthen State
activities by providing assistance in
such areas as procedural and policy
guidance, technical training, research,
consumer education, and conformity
with requirements of the NSSP Model
Ordinance; (3) provide for research
opportunities related to shellfish safety;
and (4) bring to final resolution the
development and implementation by
States and industry of effective Vibrio
risk control plans that are consistent
with current science, epidemiology, and
HACCP based food safety measures.
Substantive involvement by FDA will
include:
(1) FDA will monitor the ISSC’s
overall conduct under this cooperative
agreement.
(2) FDA will have representation on
the ISSC Executive Board, Committees,
and Task Forces.
(3) FDA will collaborate and work
closely with the ISSC on V. vulnificus
and V. parahaemolyticus risk reduction
efforts. FDA will continue to monitor
State activities to ensure illness/risk
reduction goals of the ISSC V. vulnificus
control plan are met and continue to
monitor State activities to ensure that
the ISSC V. parahaemolyticus control
plan is fully implemented.
(4) FDA will continue to work with
ISSC to develop State program
evaluation criteria.
(5) FDA will analyze State shellfish
program data and information and work
through the ISSC to resolve any State
shellfish program problems that may
impact public health.
(6) FDA will conduct training courses
in growing area classification, plant
sanitation, and HACCP and plant
standardization for participants of the
ISSC, including online training
modules.
(7) FDA will work with the ISSC to
develop new microbiological and
marine biotoxin techniques and to
develop and implement early warning
systems for toxic algal blooms and new
E:\FR\FM\28JNN1.SGM
28JNN1
Federal Register / Vol. 76, No. 124 / Tuesday, June 28, 2011 / Notices
strategies for managing areas affected by
toxic algal blooms.
(8) FDA will continue to work with
ISSC to establish improved mechanisms
for incorporating new lab methods into
the NSSP.
(9) FDA will work with the ISSC to
develop NSSP Model Ordinance
interpretations.
(10) FDA will take any action that
may be necessary to ensure compliance
with this cooperative agreement
including, but not limited to the pursuit
of science-based HACCP controls for
managing the risk of Vibrios, and
developing patrol, growing area
classification, and plant inspection
criteria.
C. Eligibility Information
Competition is limited to ISSC
because it has unique capacity found
nowhere else. ISSC is the primary
voluntary National organization of State
shellfish regulatory officials that
provides guidance and counsel to the
States and industry on matters of
sanitary control of molluscan shellfish.
ISSC is the only organization that has
the established formal structure,
procedures, and expertise to direct all
components (public health,
environmental, resource management,
and enforcement) of an effective
National shellfish safety program, and
has operated satisfactorily in this
capacity since 1993. This effort will
enhance FDA’s molluscan shellfish
safety program and provide the public
greater assurance of the quality and
safety of shellfish products.
announcement located at https://
www.fda.gov/Food/NewsEvents/
default.htm. (FDA has verified the Web
site addresses throughout this
document, but FDA is not responsible
for any subsequent changes to the Web
sites after this document publishes in
the Federal Register.) Persons interested
in applying for a grant may obtain an
application at https://grants2.nih.gov/
grants/funding/phs398/phs398.html.
For all paper application submissions,
the following steps are required:
• Step 1: Obtain a Dun and Bradstreet
Data Universal Numbering System
(DUNS) Number
• Step 2: Register With Central
Contractor Registration
• Step 3: Register With Electronic
Research Administration (eRA)
Commons
Steps 1 and 2, in detail, can be found
at https://www07.grants.gov/applicants/
organization_registration.jsp. Step 3, in
detail, can be found at https://
commons.era.nih.gov/commons/
registration/registrationInstructions.jsp.
After you have followed these steps,
submit paper applications to: Gladys
Melendez-Bohler, Office of Acquisition
and Grants Services (HFA–500), Food
and Drug Administration, 5630 Fishers
Lane, rm. 1078, Rockville, MD 20857,
301–827–7175, e-mail:
gladys.bohler@fda.hhs.gov.
Dated: June 22, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–16119 Filed 6–27–11; 8:45 am]
BILLING CODE 4160–01–P
II. Award Information/Funds Available
mstockstill on DSK4VPTVN1PROD with NOTICES
A. Award Amount
The annual allocation to the ISSC
under this cooperative agreement,
including support in the amount of
$75,000.00 from the National Marine
Fisheries Services will be $325,000.00.
Subject to the availability of Federal
funds and successful performance, 4
additional years of support will be
available. CFSAN intends to fund 1 year
of award to begin in September 1, 2011.
Subject to annual appropriations and
successful performance, 4 additional
years of noncompetitive award will be
available.
B. Length of Support
September 1, 2011, to August 31,
2016.
III. Paper Application, Registration,
and Submission Information
To submit a paper application in
response to the funding opportunity
announcement (FOA), applicants
should first review the full
VerDate Mar<15>2010
16:46 Jun 27, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
37817
Safety and Nutrition, and the Center for
Veterinary Medicine is to contribute to
the knowledge base of the current state
of food safety globally, including
challenges, risks and emerging trends,
through an integrated information
system based on WHO’s existing
network efforts.
DATES: Important dates are as follows
1. The application due date is July 20,
2011.
2. The anticipated start date is
September, 2011.
3. The opening date is the date the
notice is published in the Federal
Register.
4. The expiration date is July 21,
2011.
FOR FURTHER INFORMATION AND
ADDITIONAL REQUIREMENTS CONTACT:
For
programmatic questions and concerns
contact: Katherine Bond, Office of
International Programs, Food and Drug
Administration, 10903 New Hampshire
Ave., Silver Spring, MD 20993, 301–
796–8318; e-mail:
Katherine.bond@fda.hhs.gov.
For financial and administrative
questions and concerns contact: Gladys
M. Bohler, Office of Acquistion and
Grant Services, Food and Drug
Administration, 5630 Fishers Lane, rm.
1078 (HFA 500), Rockville, MD 20857,
301–827–7175; e-mail:
gladys.bohler@fda.hhs.gov.
For more information on this funding
opportunity announcement (FOA) and
to obtain detailed requirements, please
refer to the full FOA located at https://
www.fda.gov/InternationalPrograms/
CapacityBuilding/default.htm.
SUPPLEMENTARY INFORMATION:
I. Funding Opportunity Description
RFA–FD–11–021,
93.103: 93.103.
[Docket No. FDA–2011–N–0010]
A. Background
Cooperative Agreement With the World
Health Organization Department of
Food Safety and Zoonoses in Support
of Strategies That Address Food
Safety Problems That Align
Domestically and Globally (U01)
WHO has responsibility for the
provision of technical cooperation to its
193 Member States (national
governments) in the area of food safety
and zoonotic diseases. Among the focus
areas are: Surveillance for food borne
disease; identification of food
contamination; management of
mechanisms for information sharing;
and systems for emergency response,
including outbreak investigations and
governments’ food product recalls
which may potentially have a global
impact or cross national boundaries,
and which may fall within the
requirements of the International Health
Regulations. WHO’s technical support
complements a paradigm shift that is
emerging around the globe; a shift from
a focus on food safety interventions at
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of grant funds for the
support of a sole source cooperative
agreement with the World Health
Organization (WHO). The goal of the
Food and Drug Administration, Office of
the Commissioner and the Office of
International Programs, Center for Food
SUMMARY:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
E:\FR\FM\28JNN1.SGM
28JNN1
Agencies
[Federal Register Volume 76, Number 124 (Tuesday, June 28, 2011)]
[Notices]
[Pages 37815-37817]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16119]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0010]
Cooperative Agreement To Support Shellfish Safety Assistance
Project
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA), Center for Food Safety
and Applied Nutrition (CFSAN), Office of Food Safety is announcing its
intent to award a single source cooperative agreement to support the
Interstate Shellfish Sanitation Conference (ISSC). The purpose of this
cooperative agreement is to enhance the FDA molluscan shellfish
sanitation program and provide the public greater assurance of the
quality and safety of these products.
DATES: Important dates are as follows:
1. The application due date is July 15, 2011.
2. The anticipated start date is September 1, 2011.
3. The opening date is June 28, 2011.
4. The expiration date is July 16, 2011.
For Further Information and Additional Requirements Contact:
For Programmatic and Technical Concerns and Questions: Paul
DiStefano, Center for Food Safety and Applied Nutrition (HFS-325), Food
and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD
20740, 240-402-1410.
For Administrative and Financial Concerns and Questions: Gladys
Melendez-Bohler, Office of Acquisitions and Grants Services (HFA-500),
Food and Drug Administration, 5630 Fishers Lane, rm. 1078, Rockville,
MD 20857, 301-827-7175.
SUPPLEMENTARY INFORMATION:
I. Funding Opportunity Description
RFA-FD-11-023, 93.103.
A. Background
The CFSAN Office of Food Safety is announcing its intent to award,
a single source cooperative agreement to the ISSC in the amount of
$325,000 for fiscal year 2011, direct and indirect costs combined.
Subject to the
[[Page 37816]]
availability of Federal funds and successful performance, 4 additional
years of support will be available. This effort will enhance FDA's
molluscan shellfish sanitation program and provide the public greater
assurance of the quality and safety of these products.
Molluscan shellfish have been recognized by FDA as a significant
source of seafood-borne illnesses and continue to be the subject of
congressional, State, industry, and public concern. FDA has given high
priority to enhance the Agency's shellfish safety program and to
provide the public greater assurance of the quality and safety of these
products. FDA administers the National Shellfish Sanitation Program
(NSSP). Under that program the NSSP Model Ordinance serves as guidance
for State shellfish sanitation programs and the issuance of State
regulations and laws concerning shellfish safety. This cooperative
agreement will enhance FDA efforts to help ensure that shellfish is
free of harmful pathogens.
B. Research Objectives
This proposed cooperative agreement with ISSC will continue to: (1)
Address the need to improve information exchange and transfer among
States, Federal Agencies, industry, and consumers; (2) strengthen State
activities by providing them with procedural and policy guidance,
technical training, research, consumer education, and support for
States to participate in ISSC biennial meetings and ISSC committee
meetings; and (3) promote efforts and projects, including research,
that will contribute significantly to the ability of FDA and States to
identify and implement scientifically defensible food safety controls
to reduce the risk of illness associated with molluscan shellfish
consumption, including Vibrio vulnificus and V. parahaemolyticus.
Research efforts will provide information and data that can be used to
reduce assumptions and tighten modeling outputs of the V. vulnificus
and V. parahaemolyticus risk assessments developed by the Food and
Agriculture Organization of the World Health Organization and FDA.
Substantive accomplishments of the ISSC under previous cooperative
agreements include:
1. Coordination of annual shellfish safety meetings of Federal
regulators, State regulators, and industry members for the purpose of
developing improved science based shellfish safety controls in the NSSP
Model Ordinance for implementation by State shellfish control agencies
and the shellfish industry;
2. Facilitation of the incorporation and implementation of Hazard
Analysis and Critical Control Point (HACCP) into the NSSP Model
Ordinance;
3. Facilitation of an ISSC Unresolved Issues Process to resolve
shellfish safety program discrepancies between FDA and States, ensuring
continued compliance with NSSP shellfish safety controls;
4. Coordination of NSSP Model Ordinance revisions and electronic
online availability;
5. Coordination with FDA on the development and oversight of a V.
parahaemolyticus control plan;
6. Development of an educational training video concerning the
risks and control of illegal shellfish harvesting;
7. Development of an education training video concerning the public
health implications associated with overboard waste discharges from
harvest vessels;
8. Development of accredited online training courses for medical
professionals concerning Vibrio illness and shellfish consumption;
9. Development and maintenance of a World Wide Web site for
continuous accessibility to molluscan shellfish safety information,
including up-to-date information regarding outbreaks and recalls;
10. Coordination, development and oversight of a V. vulnificus
control plan;
11. In conjunction with FDA, conduct of retail and processing plant
product sampling studies to examine Vibrios in molluscan shellfish that
have undergone a post harvest process to reduce levels of Vibrios; and;
12. In conjunction with FDA, conduct of a retail shellfish study to
look at the occurrence of pathogens in molluscan shellfish, including
norovirus, Hepatitis A virus, Salmonella, and Vibrios; and
13. In conjunction with FDA, development of a risk-based approach
to evaluating State compliance with NSSP Model Ordinance requirements
for controlling the safety of molluscan shellfish.
Other substantive accomplishments of the ISSC include facilitating
and coordinating development of shellstock time-temperature controls
for V. vulnificus and V. parahaemolyticus; funding support for V.
vulnificus virulent strain identification research; funding support to
research the effects of ice chilling on V. vulnificus; funding support
to research the influence of water and air temperature, dissolved
oxygen, and nutrients on V. parahaemolyticus concentrations in Pacific
oysters; funding support to conduct an economic assessment of mandating
post-harvest treatment of oysters; funding support to conduct a
consumer acceptance study of oysters that have been post-harvest
treated to reduce Vibrio levels to nondetect; development of a V.
vulnificus laboratory methodology training video; and development and
broadcast of a public service announcement to alert at risk consumers
of the dangers associated raw shellfish consumption.
This project will (1) enhance both the effectiveness and uniformity
of the national molluscan shellfish safety program by improving the
flow of information between Federal and State regulatory agencies,
industry, and consumers; (2) strengthen State activities by providing
assistance in such areas as procedural and policy guidance, technical
training, research, consumer education, and conformity with
requirements of the NSSP Model Ordinance; (3) provide for research
opportunities related to shellfish safety; and (4) bring to final
resolution the development and implementation by States and industry of
effective Vibrio risk control plans that are consistent with current
science, epidemiology, and HACCP based food safety measures.
Substantive involvement by FDA will include:
(1) FDA will monitor the ISSC's overall conduct under this
cooperative agreement.
(2) FDA will have representation on the ISSC Executive Board,
Committees, and Task Forces.
(3) FDA will collaborate and work closely with the ISSC on V.
vulnificus and V. parahaemolyticus risk reduction efforts. FDA will
continue to monitor State activities to ensure illness/risk reduction
goals of the ISSC V. vulnificus control plan are met and continue to
monitor State activities to ensure that the ISSC V. parahaemolyticus
control plan is fully implemented.
(4) FDA will continue to work with ISSC to develop State program
evaluation criteria.
(5) FDA will analyze State shellfish program data and information
and work through the ISSC to resolve any State shellfish program
problems that may impact public health.
(6) FDA will conduct training courses in growing area
classification, plant sanitation, and HACCP and plant standardization
for participants of the ISSC, including online training modules.
(7) FDA will work with the ISSC to develop new microbiological and
marine biotoxin techniques and to develop and implement early warning
systems for toxic algal blooms and new
[[Page 37817]]
strategies for managing areas affected by toxic algal blooms.
(8) FDA will continue to work with ISSC to establish improved
mechanisms for incorporating new lab methods into the NSSP.
(9) FDA will work with the ISSC to develop NSSP Model Ordinance
interpretations.
(10) FDA will take any action that may be necessary to ensure
compliance with this cooperative agreement including, but not limited
to the pursuit of science-based HACCP controls for managing the risk of
Vibrios, and developing patrol, growing area classification, and plant
inspection criteria.
C. Eligibility Information
Competition is limited to ISSC because it has unique capacity found
nowhere else. ISSC is the primary voluntary National organization of
State shellfish regulatory officials that provides guidance and counsel
to the States and industry on matters of sanitary control of molluscan
shellfish. ISSC is the only organization that has the established
formal structure, procedures, and expertise to direct all components
(public health, environmental, resource management, and enforcement) of
an effective National shellfish safety program, and has operated
satisfactorily in this capacity since 1993. This effort will enhance
FDA's molluscan shellfish safety program and provide the public greater
assurance of the quality and safety of shellfish products.
II. Award Information/Funds Available
A. Award Amount
The annual allocation to the ISSC under this cooperative agreement,
including support in the amount of $75,000.00 from the National Marine
Fisheries Services will be $325,000.00.
Subject to the availability of Federal funds and successful
performance, 4 additional years of support will be available. CFSAN
intends to fund 1 year of award to begin in September 1, 2011. Subject
to annual appropriations and successful performance, 4 additional years
of noncompetitive award will be available.
B. Length of Support
September 1, 2011, to August 31, 2016.
III. Paper Application, Registration, and Submission Information
To submit a paper application in response to the funding
opportunity announcement (FOA), applicants should first review the full
announcement located at https://www.fda.gov/Food/NewsEvents/default.htm.
(FDA has verified the Web site addresses throughout this document, but
FDA is not responsible for any subsequent changes to the Web sites
after this document publishes in the Federal Register.) Persons
interested in applying for a grant may obtain an application at https://grants2.nih.gov/grants/funding/phs398/phs398.html. For all paper
application submissions, the following steps are required:
Step 1: Obtain a Dun and Bradstreet Data Universal
Numbering System (DUNS) Number
Step 2: Register With Central Contractor Registration
Step 3: Register With Electronic Research Administration
(eRA) Commons
Steps 1 and 2, in detail, can be found at https://www07.grants.gov/applicants/organization_registration.jsp. Step 3, in detail, can be
found at https://commons.era.nih.gov/commons/registration/registrationInstructions.jsp.
After you have followed these steps, submit paper applications to:
Gladys Melendez-Bohler, Office of Acquisition and Grants Services (HFA-
500), Food and Drug Administration, 5630 Fishers Lane, rm. 1078,
Rockville, MD 20857, 301-827-7175, e-mail: gladys.bohler@fda.hhs.gov.
Dated: June 22, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-16119 Filed 6-27-11; 8:45 am]
BILLING CODE 4160-01-P